Jefferies downgrades Amrize stock rating on margin concerns
Jefferies downgraded Amrize (NYSE:AMRZ) to Underperform, cutting its price target to $35.20 from $42.80. Analyst Glynis Johnson cited margin concerns due to rising costs and tough comparisons in 2027. The stock is down 23% year-to-date. Jefferies forecasts continued cost pressures will impact margins. Amrize reported Q3 2026 earnings beating profit estimates but missing revenue targets.
How this was made
The 30-second read
Why it matters
The downgrade may trigger short‑term selling, but the company's recent earnings beat and acquisition‑driven pricing resilience could limit the decline.
Market read
Analyst downgrade with a new price target is a fresh catalyst for AMRZ, likely influencing short‑term price action.
What to watch
Potential cost‑pass‑through benefits from upcoming acquisitions are not fully reflected.
Background
Jefferies issued a new research note lowering its outlook on AMRZ amid rising raw‑material, energy, and freight costs.
Ticker impact
Jefferies downgraded AMRZ to Underperform and cut its price target to $35.20, citing margin pressure.
likely pressure as the market prices in the reduced target
The downgrade is a fresh analyst action with a concrete new target, which typically triggers sell‑side activity.
Market effects
Building‑envelope and cement segments may see broader margin concerns.
U.S. construction‑materials sector could face heightened scrutiny.
Limited to investors tracking analyst coverage of mid‑cap industrial stocks.
Counterpoint
The recent earnings beat and pricing power could offset margin pressure, making the downgrade premature.
Key entities
- companyAmrize Ltd
U.S. listed building‑envelope and cement producer (NYSE:AMRZ).
- analyst_firmJefferies
Equity research firm providing the downgrade.



